Obstructive Sleep Apnea Care Pathways: Clinical Summary
A concise clinical summary addressing key learning objectives for translating cardiometabolic risk into longitudinal OSA management.
This program is supported by an independent education grant from Lilly. This online education program has been designed for healthcare professionals globally excluding the UK.
Sustained Management: Dr. Kirsch
- Longitudinal care requires managing OSA and obesity concurrently, aligning PAP therapy adherence with ongoing blood pressure and glycemic control goals.
- Clinicians should proactively troubleshoot early PAP therapy barriers—such as mask fit or pressure intolerance—at 4 to 6 weeks, focusing on problem-solving rather than blaming the patient for poor adherence.
- Care should be escalated to a sleep specialist if patients experience persistent symptoms, PAP intolerance, or worsening cardiovascular disease despite initial interventions.